moxisylyte has been researched along with Multiple System Atrophy Syndrome in 1 studies
Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sakakibara, R | 1 |
| Hattori, T | 1 |
| Uchiyama, T | 1 |
| Suenaga, T | 1 |
| Takahashi, H | 1 |
| Yamanishi, T | 1 |
| Egoshi, K | 1 |
| Sekita, N | 1 |
1 trial available for moxisylyte and Multiple System Atrophy Syndrome
| Article | Year |
|---|---|
Are alpha-blockers involved in lower urinary tract dysfunction in multiple system atrophy? A comparison of prazosin and moxisylyte.
Topics: Adrenergic alpha-Antagonists; Aged; Female; Humans; Male; Middle Aged; Moxisylyte; Multiple System A | 2000 |